Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.6000 (-0.24%) ($28.2100 - $28.9000) on Thu. Oct. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2% (three month average) | RSI | 72 | Latest Price | $28.6000(-0.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.5% a day on average for past five trading days. | Weekly Trend | HALO advances 4.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(48%) IWM(47%) IWC(44%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1% in a week (0% probabilities). VIXM(-31%) UUP(-14%) VXX(-13%) EDOC(-5%) DRIV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1% (StdDev 2%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $28.52(0.28%) | 10 Day Moving Average | $27.76(3.03%) | 20 Day Moving Average | $27.09(5.57%) | To recent high | -3.4% | To recent low | 11.2% | Market Cap | $3.909b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |